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California; and Physical Biosciences Division, Lawrence Berkeley National Laboratory, Berkeley, CaliforniaABSTRACT Integrin aIIbb3 is a member of the integrin family of transmembrane proteins present on the plasma membrane of
platelets. Integrin aIIbb3 is widely known to regulate the process of thrombosis via activation at its cytoplasmic side by talin and
interaction with the soluble fibrinogen. It is also reported that three groups of interactions restrain integrin family members in
the inactive state, including a set of salt bridges on the cytoplasmic side of the transmembrane domain of the integrin a- and
b-subunits known as the inner membrane clasp, hydrophobic packing of a few transmembrane residues on the extracellular
side between the a- and b-subunits that is known as the outer membrane clasp, and the key interaction group of the bA domain
(located on the b-subunit head domain) with the bTD (proximal to the plasma membrane on the b-subunit). However, molecular
details of this key interaction group as well as events that lead to detachment of the bTD and bA domains have remained ambig-
uous. In this study, we use molecular dynamics models to take a comprehensive outside-in and inside-out approach at exploring
how integrin aIIbb3 is activated. First, we show that talin’s interaction with the membrane-proximal and membrane-distal regions
of integrin cytoplasmic-transmembrane domains significantly loosens the inner membrane clasp. Talin also interacts with
an additional salt bridge (R734-E1006), which facilitates integrin activation through the separation of the integrin’s a- and
b-subunits. The second part of our study classifies three types of interactions between RGD peptides and the extracellular
domains of integrin aIIbb3. Finally, we show that the interaction of the Arg of the RGD sequence may activate integrin via dis-
rupting the key interaction group between K350 on the bA domain and S673/S674 on the bTD.INTRODUCTIONIntegrins are a family of extracellular matrix (ECM) binding
proteins that consist of 25 heterodimeric members. Each
integrin molecule is composed of a a and a b noncovalently
associated subunits. Each integrin subunit consists of a large
extracellular domain (ectodomain), a single-pass transmem-
brane helix, and a short cytoplasmic tail (1,2). Integrins play
a host of crucial roles in a variety of cell functions, including
linking focal adhesion assemblies to the ECM, facilitating
cell migration, transmitting signals bidirectionally, and con-
trolling cell growth, differentiation, and apoptosis (2–6).
Additionally, clustering of integrins is known to be a critical
regulator of the focal adhesion size (7–9). Integrin aIIbb3,
which is the major integrin type expressed on the surface
of platelets, plays a critical role in platelet aggregation
and blood clotting (10,11). Therefore, integrin aIIbb3
malfunction is marked by several diseases such as throm-
bosis in myocardial infarction, ischemic stroke, peripheral
arterial disease, and Glanzmann thrombasthenia bleeding
disorder (11,12). Integrin aIIbb3 is activated via inside-
out and/or outside-in signaling mechanisms, and these two
pathways are reported to be discrete while having mutual
effects on each other (1,2,13).
The inside-out activation of integrins is defined as the
process of activation that is triggered by a cytoplasmic
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0006-3495/13/09/1304/12 $2.00domain for the ligand. Inside-out activation processes
modulate integrin aIIbb3 affinity for extracellular ligands
(i.e., fibrinogen) through binding of key cytoplasmic pro-
teins (see Fig. 1). Among the various proteins that bind
integrins and link them to the actin cytoskeleton, talin and
kindlin are reported to activate integrin via associating
with the cytoplasmic tail of the integrin b-subunit (4,14).
The most well-known inside-out activation cascade for
integrin aIIbb3 is triggered by binding of cleaved thrombin
to proteinase-activated receptor 1 (PAR1) located on the
plasma membrane of human platelets. This binding leads
to phospholipid hydrolysis, which results in the generation
of inositol trisphosphate (IP3) and diacylglycerol (DAG),
and an increase in cytosolic free Ca2þ. The elevated concen-
tration of Ca2þ and DAG, which in turn activates CALDAG-
GEFl and protein kinase C (PKC), converts RAP1 from a
GDP-bound to a membrane-attached, GTP-bound form.
Activation of RAP1 leads to recruitment of its effectors,
RAP1-GTP-interacting adaptor molecule (RIAM), and its
binding partner, talin 1, to the plasma membrane. This facil-
itates access of talin to the integrin b3 tail and talin-induced
activation of integrin aIIbb3 (4). Two major interactions
attach the transmembrane domains of the a- and b-subunits:
the outer membrane clasp (OMC) embedded within the lipid
bilayer and the inner membrane clasp (IMC) located near
the membrane-proximal (MP), cytoplasmic tail between
the integrin subunits (2). Upon release of these clasps, the
transmembrane-cytoplasmic domains of integrin are sepa-
rated and activated, causing the extracellular domains to
become more receptive to ECM ligand binding. Bindinghttp://dx.doi.org/10.1016/j.bpj.2013.07.055
FIGURE 1 A schematic of one of the main pathways of integrin aIIbb3
inside-out activation. Binding of thrombin to PAR1 causes separation of the
talin head and tail domains. Consequently, the talin head domain associates
with the b3 subunit cytoplasmic domain, activating integrin aIIbb3.
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factors that disrupts the interactions between the two integ-
rin subunits, separating the transmembrane-cytoplasmic
domains (14). The current study provides molecular-resolu-
tion simulations that show how talin head domain binding to
the transmembrane-cytoplasmic domain of the integrin b3
subunit mechanically loosens the IMC.
On the other hand, the outside-in activation is identified
by interactions of the integrin extracellular head domain
with the ECM ligand or divalent cations that lead to partial
unfolding of the extracellular domain and separation of
integrin subunits. The integrin b3 subunit is known to be
the major regulator of activation for integrin allbb3 and
avb3 (15,16). Binding of divalent cations with the integrin
head domain (i.e., bA and b-propeller domains on the extra-
cellular side) is reported to determine the integrin activation
state. There exist three divalent metal ion binding sites on
the integrin bA domain. The first one, termed as the metal
ion-dependent adhesion site (MIDAS) is coordinated with
Mg2þ, although the two other cation binding sites, called
the adjacent to MIDAS (ADMIDAS) and ligand-induced
metal binding site (LIMBS) located on the opposite sides
of MIDAS, are coordinated with Ca2þ (15,17,18). High con-
centrations of Ca2þ reinforce the bent, inactive state of
integrin avb3, whereas in the presence of Mn2þ, a cation
that activates integrins, most integrin aIIbb3 molecules
observed by electron microscopy were in an extended
conformation (19). It is proposed by some researchers that
the RGD ligand and divalent cation share a common binding
pocket on the integrin b3 head domain on the interface of
the bA and b-propeller domains (20,21). Importantly,
external force has also been shown to directly activatecertain types of integrin and prolong their ligand-bound life-
time (20,21). Last but not least, the integrin head domain
interaction with the ligand at the metal ion-dependent
binding sites is shown to activate integrins though its details
are not yet fully agreed upon. Furthermore, whether an
interaction between the CD loop of the bTD and the b6-
a7 loop of the bA domains regulates integrin activation
remains highly controversial (22,23). Hence, we explored
potential effects of RGD-binding to integrin allbb3 through
positioning two soluble RGD peptides proximal to the metal
ion-dependent binding sites and one near the bA-bTD do-
mains interface.
Two mechanistic models are widely invoked to describe
the behavior of integrins: the switchblade and the dead-
bolt model (24). According to the switchblade model, integ-
rins take on three distinct conformations, corresponding to
their inactive, active, and ligand-bound states. The inactive
state of integrin is featured by a bent-over configuration
wherein the molecule shows a low affinity for ECM ligands
(see Fig. 1) (24). Furthermore, in the inactive state, IMCs
and OMCs hold the transmembrane domains of integrin
together (1). Integrin activation results in a stretched confor-
mation and breakage of the IMCs and OMCs, most likely
via presence of a competing molecule (e.g., talin and kind-
lin) that occupies these binding sites on the transmembrane
domain of the integrin b-subunit (2,4). Activated integrin
is known to have a significantly higher affinity for ECM
ligands (19). Finally, the ligand-bound state takes place
when the integrin head domain engages in an interaction
with an ECM molecule (e.g., fibronectin and fibrinogen).
The ligand-bound conformation differs from the nonbonded
active state in that the integrin head domain introduces
an opening between the a- and b-subunits when in the
ligand-bound state (23,25). Alternatively, the deadbolt
model suggests a significantly smaller conformational
change, wherein a hairpin loop between b-strands C and
D of the b3 tail domain (i.e., the CD loop), located on the
b-subunit proximal to the plasma membrane, functions as
a dead bolt. Upon release of the CD loop, the integrin mole-
cule is activated, as the bonding between the bTD (proximal
to the plasma membrane) and the bA domains on the integ-
rin head domain is lost (23,26,27).
Despite numerous experimental studies conducted to
shed light on the elaborate mechanism of integrin allbb3
activation from inside-out as well as outside-in perspectives,
the atomistic details of either of these mechanisms have
remained ambiguous (4,13). In this study, we developed
molecular dynamics (MD) models to probe details of
inside-out and outside-in activation of integrin aIIbb3 via
integrin-talin interactions. It has been shown previously
that outside-in signaling pathways of integrin aIIbb3 are
spatially distinct from those of inside-out activation in
platelets (13). Hence, this study chose to dissect two of
the most established pathways for integrin aIIbb3 activation
in molecular details: Talin binding to the cytoplasmicBiophysical Journal 105(6) 1304–1315
FIGURE 2 Crystal structure of integrin aIIbb3 embedded in the plasma
membrane. Three RGD peptides (green) are positioned in potential binding
regions of integrin. The only RGD sequence that interacted with the integrin
molecule was the one located near the bTD-bA pocket (RGD3). The aIIb
and b3 subunits are depicted in red and blue, respectively.
1306 Mehrbod et al.domain of the b3 subunit to represent the inside-out activa-
tion, and RGD binding to the ectodomain to simulate the
outside-in activation. First, we estimated the strength of
the integrin transmembrane bonds (i.e., IMCs and OMCs)
and showed that the presence of the talin head domain
bound to the cytoplasmic domain of the integrin b-subunit
markedly loosens the IMC such that a lower external force
is required to separate the transmembrane domains of the
a- and b-subunits. We focused our attention on the talin-
integrin b3 interaction as the last step of a major cascade
of events that leads to integrin activation to show, in
molecular details, the contribution of this critical event in
dissociating the integrin transmembrane domains. Further-
more, using the full-length crystal structure of integrin
including the ectodomain and transmembrane-cytoplasmic
domains for the first time to the best of our knowledge,
we identified a number of potential binding sites of the
soluble RGD ligand to the integrin head domain. Based on
these results, three likely mechanisms are proposed for
integrin-ligand binding. Finally, we explored the dead-bolt
model in atomic details, mapping out three key residues
that act as the dead bolt.METHODS
Interactions of RGD peptides with full-length
integrin
All MD simulations were carried out with the program NAMD (28), using
CHARMM27 force field. The integrin allbb3 ectodomain (PDB ID: 3FCS
chains A and B (29)) and the transmembrane-cytoplasmic domains (PDB
ID: 2KNC (46)) were obtained from the Protein Data Bank (PDB) and com-
bined to build the full-length integrin aIIbb3 structure (except residues
954–959 of the a-subunit and 684–690 of the b-subunit), assuming covalent
bonds between residues C959 and G955 on the a-subunit and G684 and
G690 on the b-subunit. The integrin structure was embedded in a patch
of POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) lipid bilayer
with dimensions of 152  113 A˚, using the software VMD (30). In all
simulations, lipid chains overlapping with the transmembrane domain
were removed afterward. PDB files of three RGD peptides were manually
produced and positioned in proximity of the integrin head domain as shown
in Fig. 2. The system was solvated afterward in a water box with an ionic
KCl concentration of 150 mM (31).
The pressure and temperature of the system were held constant at 1 atm
and 310 K, respectively, using Langevin’s piston and Hoover’s method (28).
The time step was taken as 2 fs. The cutoff distance for nonbonded interac-
tions was 1.2 nm. For all simulations, the particle mesh Ewald method was
used for electrostatic force calculations (28). The cutoff distance for
nonbonded interactions was 1.2 nm. The hydrogen atom bond length was
constrained using the SHAKE method. The SHAKE method fixes bond
lengths between large atoms and hydrogen atoms, preventing unnecessary
calculation of irrelevant interactions (32). The system was minimized, at
2000 steps, and equilibrated six times with RGD peptides present and
once with no RGD peptide in the system as control, each time for ~13 ns.Integrin-talin binding
The crystal structure of the transmembrane and cytoplasmic domains of
integrin aIIbb3 was embedded in a patch of POPC. The first step in our
simulations was to induce the talin-1 FERM head domain to bind to integrinBiophysical Journal 105(6) 1304–1315aIIbb3, which are known to bind to each other (33,34). A model was
created, using the molecular graphics software VMD, with the transmem-
brane-cytoplasmic regions of integrin aIIbb3 (PDB ID: 2KNC (35))
embedded in a POPC lipid bilayer (30). The Talin-1 FERM head domain
(PDB ID: 3IVF (36)) was placed with the F3 (PTB-like) domain, facing
the integrin b3 subunit with a 27A˚ distance between the center of mass
of the F3 domain (L320) to b3 residue W739. The system was solvated,
then neutralized and ionized to a concentration of 150 mM NaCl. The sys-
tem underwent minimization (2000 steps) and equilibration for 7 ns, before
each center of mass in the F0–F3 talin domains was given a nudge for 1 ns
(k ¼ 0.07 kcal/mol/A˚2; velocity ¼ 17.5 A˚/ns) in the direction that mini-
mizes the mentioned 27 A˚ distance. Following that, the system was allowed
28 ns to equilibrate. At the end of the total 36 ns, we nudged the F0 domain
of talin for 1 ns (k ¼ 0.06 kcal/mol/A˚2, velocity ¼ 12.5 A˚/ns) to tilt the F3
domain of talin toward the integrin b3 subunit. This was performed to
promote the MP interactions between F727 and F730 on the b3 subunit
to the S1-S2 loop of talin F3 (33). Following that, the system was equili-
brated for 9.5 ns.Simulation and analysis of integrin-talin
interactions using full-length integrin structure
Having obtained a full-length integrin aIIbb3 structure, we placed it inside
a membrane, solvated and ionized it with 150 mM NaCl, and ran a minimi-
zation and equilibration simulation for 6 ns. Next, with our equilibrated
full-length integrin structure, a similar model consisting of integrin and
talin-1 FERM head domain was built, with a similar orientation and initial
distance maintained between the integrin b3 subunit and F3 domain of
talin-1. This model was minimized and equilibrated for 4 ns, 10 times to
get a random sample of velocities and trajectories. From the simulations,
we measured the final distance (at ~4 ns) between R734-E1006, between
the aIIb and b3 extracellular domains, between the bTD and bA domains,
and between the center of masses of selected regions of the b3 subunit of
integrin and talin-1 F3 domain. Finally, the Spearman’s tests of dependence
were performed to further pinpoint which region of the b3 subunit tail is
correlated to the weakening of this additional interaction and whether the
degree of talin binding to the integrin b3 subunit affected integrin’s extra-
cellular conformation. (Details for the comparison of the IMC interactions
and other results in integrin versus integrin-talin systems are included in
the Supporting Material.)
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Interactions between the soluble RGD and
integrin potentially activates integrin aIIbb3
To probe likely binding sites of the soluble ligand, RGD
sequences were placed at three locations proximal to the
integrin head domain previously reported as potential bind-
ing spots of integrin for fibrinogen (15,18,23). Depicted
in Fig. 2 are locations of the three soluble RGD ligands
relative to the integrin molecule. Two RGD peptides
were positioned in the vicinity of the interface between
the b-propeller domain of the a-subunit and the bA domain
of the b-subunit, whereas another RGD peptide was located
in proximity of the pocket formed by the bA and bTD
domains of the b-subunit. Fibrinogen is a large macromole-
cule with a low transformational and rotational diffusion
coefficient (37). Therefore, identifying the potential binding
sites of the fibrinogen on the integrin head domain requires
an excessive amount of computational time, i.e., several
seconds or even longer, which is beyond the timescale of
current MD models. Hence, merely a functional part of
the fibrinogen molecule, i.e., the RGD sequence, was
located close to the integrin head domain and allowed to
diffuse freely.
The integrin molecule embedded in the lipid bilayer was
solvated in a water box, minimized in 2000 steps of 2 fs, and
equilibrated for no less than 13 ns. The three RGD peptides
diffused throughout the water box until they formed inter-
actions at various regions on the integrin head domain.
The simulation was repeated seven times, corresponding
to a total of ~104 ns. RGD peptide 3 (RGD3) interacted
with various binding sites located on the integrin head
domain and/or within the inner pocket formed by the bent
molecule (see Fig. S1). However, RGD peptide 1 and 2
(RGD1 and RGD2) combined interacted with a more
limited number of binding sites on the interface of the bA
and b-propeller domains. Intriguingly, RGD3 was confined
to the bA-bTD pocket region in all simulations, whereas
RGD1 and RGD2 remained associated with the head
domain only in half of the simulations. Interactive residues
on each subunit are shown in Table S1.
Interactions that lasted for a minimum of ~3 ns after their
initial formation were called permanent bonds as opposed to
those formed only intermittently, termed temporary bonds
hereinafter. Depicted in Fig. S1 is the distance between
interacting residues of integrin within the bA-bTD pocket
region and RGD3. It is noteworthy that interactions between
the RGD peptide and extracellular domain of integrin are
mainly salt bridges, as the RGD peptide is equipped with
a strong basic residue and a highly acidic one (i.e., Asp
and Arg) with long side chains at its two ends that are
separated by a small hydrophobic spacer (i.e., Gly). For
this reason, all permanent bonds shown in Fig. S1 are
of ~4.5 A˚ bond length, which is the characteristic length
of a salt bridge (38,39).According to the nature of bonds in the simulated trajec-
tories, integrin-RGD bindings were classified into three
major groups; the first group (i.e., type1 bond) comprised
interactions with only a single, permanent interaction
between the RGD peptide and integrin as shown in
Fig. S1 a and b. Permanent bonds were formed as a result
of type1 bonds with minimal fluctuations in all cases. The
bond distance between the Arg of RGD3 and D817 on the
Calf2 domain of the a-subunit is presented in Fig. S1,
whereas Fig. S1 b shows the bond distance between the
Arg of RGD3 and D127 on the bA domain of the b-subunit.
The second type of binding that occurred in two of our
simulations included bindings in which one side of the
soluble RGD peptide interacted permanently with the bA
domain on the integrin head domain, whereas the other
end only showed temporary engagement with membrane
proximal domains of integrin. In one simulation, the Arg
side of the soluble RGD formed a permanent bond with
E312 on the bA domain (see Fig. S1 c). This interaction
served as an anchorage for the ligand while the other side
interacted temporarily with K650 on the bTD. Another
permanent interaction formed between the Arg of RGD3
and D232 of the b-propeller domain of the aIIb subunit,
whereas the Asp side of RGD3 formed a temporary inter-
action with N313 on the bA domain (see Fig. S1 d).
The other, and the most complex, type of interactions
involved one permanent binding site and two temporary
interactions on the integrin molecule that competed with
each other. This group of interactions featured one end of
the free RGD peptide tethering to the b-subunit permanently
with other short-term bindings also taking place at the other
end of the RGD peptide. For instance, Fig. S1 e shows a
permanent bond between the Arg of RGD3 and D628 on
the Calf1 domain of the a-subunit (blue) as well as the
temporary bonds between the Asp of RGD3 with R897 on
the Calf1 domain of the a-subunit (green), and K600 on
the linker region between the EGF-1 and bTD (red).
Although partial detachments were seen in a few of the sim-
ulations, a full separation of the bTD and bA domains was
only observed in one out of six RGD-included simulations,
when RGD3 interacted with three binding sites as depicted
in Fig. S1 f. A permanent, polar interaction (as shown in
blue in Fig. S1 f) was formed between the Arg of RGD3
and E671 on the bTD. Importantly, it was observed that
the electrostatic interactions of S673 and S674 on the
bTD with K350 serve as a key for activation of integrin
aIIbb3, as depicted by Fig. 3. This simulation was run
for ~21 ns. The key residues on the bTD (i.e., S673 and
S674) continued to interact with K350 until t ¼ 7.5 ns
(see Fig. 3 c). However, as the Arg of the RGD peptide
reached the vicinity of S674 at t ¼ 7.5 ns, the Arg of the
RGD peptide competed with K350 for S674 and the key
interaction was highly disturbed (Fig. 3 d). Finally, the
key interaction was fully removed as the Asp of the RGD
peptide engaged in a competitive interaction with K600Biophysical Journal 105(6) 1304–1315
FIGURE 3 The Arg of the RGD peptide disrupts
the bA-bTD interactions via competing with K350
on the bA domain for S673. (a) The bA and bTD
are attached in the inactive, bent state of integrin.
(b) The bTD swings open and separates apart
from the bA domain, which leads to integrin acti-
vation. (c) Focusing further into the bTD-bA
pocket shows the key interaction between K350
and S673/S674 that keeps integrin inactive. (d)
The RGD peptide approaches S674 and interacts
with it, disrupting the key interaction between the
bTD and bA domains. (e) Although the Arg of
the RGD peptide is bound to E671 and S674, the
Asp of the RGD peptide switches back and forth
between K600 and K611. This competitive interac-
tion on the Asp side of the RGD peptide shifts the
bTD further toward the EGF3/4 domains and apart
from the bA domain.
1308 Mehrbod et al.and K611, pulling the bTD away from the bA domain
(Fig. 3 e). As a result of the RGD peptide replacing K350
on the bA domain, the bTD swung open, separating from
the bA domain (see Fig. 3 a and Fig. 4 b). The open confor-
mation of the bTD appeared to be stable insofar as the bTD
remained open for another 4.5 ns until the end of the simu-
lation, as shown in Fig. S2. Finally, we repeated the simu-
lation one more time without any RGD peptides included.
As expected, the bTD and bA domains remained attached
in the absence of an RGD peptide.
We observed that the dissociation of the bTD and bA
domains caused the bTD to snap back, which induced a
slight rotation in the b-subunit transmembrane domain
(~3 over the course of our simulations) in a lever-like
motion. This rotation increased the angle between the
a- and b-subunit transmembrane domains. We conducted
energy analyses to measure the electrostatic energy between
the a- and b-subunit transmembrane domains for the case
where there was no RGD peptide as well as for the case
where the integrin activation was observed. Interestingly,
the electrostatic energy of interaction appeared to decrease
dramatically after the bTD and bA domains separated
(see Fig. 4 a). A tiny rotation of the long, b-subunit trans-
membrane domain increased the distance between acidic
and basic residues on the a- and b-subunit transmembrane
domains that considerably weakened the IMC.Integrin-talin binding
To study the effect of talin on integrin activation, we first
needed to create two separate conditions: the experimental
condition, integrin with talin bound, and the control, integ-
rin alone. To create our experimental condition, we pro-Biophysical Journal 105(6) 1304–1315moted the binding of talin to integrin through a series of
equilibration and steering simulations. After the 48 ns of
equilibration and nudging, we observed binding between
integrin and talin. Our results match that of the suggested
mode of binding in the literature (2).
First, hydrophobic packing is evident between conserved
residues and motifs, W739 and NPLY (744 to 747), on the
integrin b3, and residues on the F3 domain of talin. The
identified residues on the F3 domain of talin that bind to
W739 on the integrin b3 subunit are the residues R358
and A360 on the S5 b-sheet on talin, which form a pocket
for W739 (40). Additionally, the NPLY motif interacts
with these S5 residues and additional residues, A389,
Q390, A393, and I398, on the final H1 helix of the F3
domain (Fig. 5). Finally, after the nudges to tilt talin, as
expected, F727 on the b3 subunit embedded itself into the
talin S1-S2 loop region strand, consisting partly of residues
K318, M319, and K320 (33).Effect of talin binding on integrin
Using the integrin-talin and integrin-alone models, we ran-
domized the initial velocities in 12 repetitions, equilibrated
for 5 ns, and pulled apart the IMC for 5 ns. The IMC of
integrin changed its conformation upon binding talin. Three
parameters were used to quantify the state of the IMC.
The average distance between the carbon-a atoms of
D723–R995 and E726–R995 shows that talin induces a
bulge in the IMC even before the steered separation. The
mean distances, as indicated by distance d in Fig. S3, for
both the integrin-talin and integrin alone conditions were
9.8 A˚ and 13.5 A˚, respectively, and this difference was sig-
nificant using a permutated two-sample, one-tailed, t-test
FIGURE 4 (a) The interaction energy between
the integrin transmembrane-cytoplasmic domains
of the a- and b-subunits as the simulation pro-
gresses for the integrin activation case as well as
for the simulation with no RGD peptide. The initial
5 ns of the simulation shows the preequilibration
phase, where both systems show similar interaction
energies of ~250 kCal/mol. This energy finally
reaches a stable state at ~200 kCal/mol in the
absence of an RGD peptide. However, for the
case where separation between the integrin bTD
and bA domains occurs, the energy of interaction
between the transmembrane-cytoplasmic domains
of integrin significantly drops to ~100 kCal/mol.
This difference highlights a potential underlying
mechanism that could loosen and eventually break
apart the electrostatic interaction that holds the
transmembrane-cytoplasmic domains of integrin
together, as a result of an RGD-induced outside-
in activation. (b) A schematic of integrin aIIbb3
immediately after activation via RGD binding to
the bTD. The integrin bTD and bA domains are
bound by the key interaction group. Insertion of
an RGD peptide into the bTD-bA pocket leads to
a separation between the bTD and bA domains
that somehow unbend integrin and loosens the
electrostatic interaction between the integrin trans-
membrane domains via rotating the transmem-
brane domain of the b-subunit.
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this increase in distance, the interaction energy between
the acidic b3 and basic aIIb IMC residues was also dimin-
ished (corresponding to less negative energy, see Fig. 6, a
and b). The mean nonbonding energy for the integrin-talin
systems was 93.4 kcal/mol and for the integrin-only sys-
tem was 133.4 kcal/mol (Fig. 6), and again this difference
was significant (p < 0.002). More interestingly, in all
12 simulations, the interaction energy between the IMC
residues was never stronger than 129.7 kcal/mol in integ-
rin-talin simulations, whereas the strongest observed energy
was 163.6 kcal/mol in the integrin-only simulations.
The last parameter investigated was the force required
to break apart the IMC. As expected, with talin bound to
integrin, the force required to break the IMC was lower
than without talin. The mean force required, given the
spring constant of k ¼ 0.05 kcal/mol/A˚2 and the constant-
pulling velocity 10 A˚/ns of the carbon-a atom of R995
while fixing the carbon-a atoms of D723/E726, was
224.6 5 9.75 pN with talin bound and 249.8 5 12.2 pNwith integrin only (mean5 standard error). This difference
was slightly significant (p < 0.04). These differences in
initial energies, distances, and forces between the integrin-
talin and integrin-alone conditions were confirmed with
the difference in work of ~1000 kcal/mol required to sepa-
rate the IMC, up to 16 A˚ of separation (Fig. 6 c). In addition,
with the integrin-talin simulations, a basic residue, K320, on
talin’s S1-S2 loop interacted with the integrin b3 IMC res-
idue D723 before and after the breakage of the IMC, with
interaction energies of 75.2 kcal/mol and 84.5 kcal/mol,
respectively.
One interesting difference between the integrin-talin
versus the integrin-only system is that there is an additional
salt bridge interaction between R734 on the b3 and E1006
on the aIIb subunit with the integrin-talin system (Fig. 6).
Quantitatively, we observed that the distance between the
most terminal carbons on R734 and E1006 was significantly
different between the integrin-talin (5.25 A˚) and the integrin
only (16.1 A˚) conditions, with p < 0.0003 (see the Support-
ing Material).Biophysical Journal 105(6) 1304–1315
FIGURE 5 (a) Initial simulation position of the
integrin aIIbb3 transmembrane-cytoplasmic do-
mains (PDB ID: 2K9J) and talin-1 FERM domain
(PDB ID: 3IVF). For the new-cartoon represen-
tations, in red is the aIIb subunit of integrin, in
blue is the b3 subunit of integrin, and in silver is
the talin-1 FERM domain. For van der Waals
sphere representations, in orange are the acidic res-
idues E1006 (on aIIb) and D723 (on b3) of
integrin, in cyan are the basic residues and R734
(on b3), in green are the residues F727, F730,
and W739 on b3, in pink is the NPLY motif, in
brown are residues R358, A360, A389, Q390,
A393, and I398 on the talin F3 domain, and in
yellow is K320 of the S1-S2 loop on the talin-1
F3 domain. Note that the atoms shown with the
CPK representation in cyan (R995, aIIb) and
orange (E726, b3) are tightly bound to hold the
IMC together. These highlighted residues play an
important role as shown by our simulations.
(b and c) Talin-1 F3 domain (F0–F2 not shown)
binding with the NPLY motif and W739 on the in-
tegrin b3 subunit. The left rendering (b) highlights
NPLY motif binding to the H1 helix; whereas the
right rendering (c) highlights W739 binding in
the pocket formed by R358 and A360 in talin.
The picture was taken 24 ns after the start of the
simulation.
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Using the full-length integrin structure, we assessed the
effects of the F3 domain of talin binding to specific local
regions on the integrin b3 cytoplasmic tail. Focusing on
this additional interaction, R734-E1006, we found an over-
all negative correlation between the center of mass distances
of the integrin b3 cytoplasmic tail to the talin F3 domain and
distance between R734 and E1006. In other words, as the
talin F3 domain approaches the integrin tail, the distance
between R734 and E1006 enlarges, which also results in
lower interaction energy. Upon closer analysis (see Table
S2), a stronger correlation is observed when selecting the
dependent variable as the center of mass of a subdomain
of the cytoplasmic b3 subunit, specifically the region from
the NPLY motif onward (termed NPLY-T762), to measure
the distance to the center of mass of the F3 domain of talin
(rho ¼ 0.82, p ¼ 0.0038). This suggests a greater signifi-
cance in the membrane-distal binding of the b3 integrin to
the F3 domain of talin-1. Similarly, we also examined the
potential conformational changes in the integrin extracel-
lular domain followed by the F3 domain of talin binding
to the integrin b3 cytoplasmic tail. The degree of talin bind-
ing did not show any significant effects to alter integrin
extracellular conformation (Table S3).Biophysical Journal 105(6) 1304–1315DISCUSSION
Although integrin has been a subject of intensive study over
the past two decades, molecular details of its function have
remained ambiguous (3,23,24). As shown in Fig. 1, interac-
tion of PAR1 with thrombin triggers the integrin aIIbb3
activation pathway, which finally leads to thrombosis
(1,4,41). Therefore, understanding how integrin aIIbb3
functions paves the road for deciphering pathways that regu-
late thrombosis (41,42). We have successfully used MD
techniques to model mechanosensitive focal adhesion pro-
teins (7,43–49). Here, we performed a series of MD simula-
tions to observe how exposing integrin aIIbb3 to soluble
RGD peptides as well as the talin head domain may affect
the integrin structure. Integrin aIIbb3 is a highly studied
member of the integrin family, which is present in platelets,
enabling them to interact with soluble fibrinogen (a special-
ized ligand of integrin aIIbb3 that exists abundantly in the
blood stream). It is widely known that soluble fibrinogen
binds the head domain of integrin aIIbb3, initiating the
blood clotting process by forming a network of fibrinogen
ligands with platelets trapped inside it (42,50,51).
Approaching integrin aIIbb3 from the intracellular
perspective, to our knowledge, we believe that we have
uncovered new biomolecular, mechanistic details on the
FIGURE 6 (a and b) Total nonbonding (van der
Waals and electrostatic) energy between the IMC
residues R995 on the aIIb, and D723 and E726
on the b3 subunits for the steered molecular dy-
namics (SMD) simulations, where the aIIb R995
carbon-a atom was pulled (k ¼ 0.05 kcal/mol/
A˚2, velocity ¼ 10 A˚/ns) and the b3 D723 and
E726 carbon-a atoms were fixed. The colored lines
represent the raw data from each of the 12 trials per
condition, whereas the dark black line indicates the
average of these trials. The two vertical dark gray
bars within the first 100 ps indicate the averaged
region to obtain the initial nonbonding energy
before performing SMD. The graph on the left
(a) is the integrin-alone condition, whereas the
right (b) is with talin bound to integrin. (c) Work
done by the SMD simulations to separate the
IMC, as a function of the amount of distance
between the carbon-a atoms.
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that talin is required for inside-out activation of integrin, the
specific mechanism of how integrin is activated by talin is
uncertain (52). The current working model suggests that
talin binding to the cytoplasmic tail of the b3 subunit would
occur first at the membrane-distal region, which then
promotes a MP interaction to take place between talin and
integrin b3 subunit. This MP interaction is where the mech-
anism of activation arises (53). Our data suggest a similar
mechanism, in that b3 subunit F727 embedding in the talin
S1-S2 loop may help the IMC salt bridge to loosen its grip
because this allows the basic K320 residue to energetically
compensate for the IMC salt bridge loss. Furthermore, in
the timescale of our simulations, we did not observe signif-
icant conformational changes in the integrin extracellular
domains though previous work suggested that breakage of
the IMC salt bridge by talin is necessary but not sufficient
to fully activate integrin (53).
Additionally, we observed a salt bridge interaction
between the most membrane distal regions of the aIIb
and b3 integrin subunits with residues E1006 and R734,
respectively. Interestingly, this interaction appeared in two
of the four separate simulation conditions, forming in the
integrin-talin bound simulations using only the cyto-
plasmic-transmembrane domains of integrin, and in the
integrin-alone simulations using the full-length integrin
aIIbb3. We make two propositions, the first of which states
that this interaction may be an artifact of using only the
cytoplasmic-transmembrane domains of integrin. Second,
the default presence of this interaction using full-length in-
tegrin suggests that talin plays an even more important
role in integrin activation. This artifact in the cytoplasmic-transmembrane simulations may cause the force and work
required to separate the IMC under the integrin-talin condi-
tions to be overestimated. Without this interaction, the in-
tegrin-talin conditions may be even more favorable toward
IMC separation and integrin activation. More interestingly,
it seems that the membrane-distal interactions of talin and
integrin are important for more than solely providing an
anchor for the MP interactions to weaken the IMC (53).
Instead, we propose that the binding of talin to the mem-
brane-distal region of the b3 subunit cytoplasmic tail
weakens this salt bridge E1006-R734 interaction, which is
the first step in integrin inside-out activation.
Integrin is also activated via association with an extra-
cellular ligand, a process called outside-in activation. It is
reported that integrin aIIbb3 has a high affinity for the
RGD sequence of fibrinogen (3,11,54). Interactions between
integrin aIIbb3 and fibrinogen are reported to occur on the
interface of the b-propeller domain of the aIIb and the bA
domain of the b3 subunit. In particular, RGD peptides are
shown to associate with a region of the b3 defined by
D109 and E171 as well as another region limited to S211
and G222 (20,21). Nonetheless, a number of studies showed
that the integrin aIIbb3 head domain interacts solely with a
C-terminal region of fibrinogen (i.e., gC) rather than
the RGD sequences on the fibrinogen a-subunit (15,18).
To address this controversy making best use of the com-
putational time, instead of modeling the entire fibrinogen
molecule, we placed two RGD sequences at regions of the
integrin aIIbb3 head domain that had been reported to
have high affinity for fibrinogen (3,15). An RGD peptide
was positioned in the vicinity of the bTD-bA domain inter-
face, another sensitive region that is suggested to contributeBiophysical Journal 105(6) 1304–1315
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especially ones that could regulate integrin function. The
small size of RGD peptides conferred upon them high
diffusivity and capability to sweep the space in the vicinity
of the sensitive areas of integrin aIIbb3. We initiated our
simulations with inactive integrin aIIbb3, wherein the bA
domain of the integrin head domain is attached to the MP
bTD. This forms a pocket-like configuration between the
integrin head domain andMP region, which is geometrically
appropriate for the long, coiled-coil molecule of fibrinogen
to insert into. Because the RGD motif of fibrinogen is
located on the surface of the g-subunit of fibrinogen, it
has high potency for detecting RGD-sensitive regions of
integrin aIIbb3.
The association constant for the integrin-peptide inter-
action is
ka ¼ ½IP½I½P; (1)
where [I], [P], and [IP] are concentrations of integrin,
free RGD peptide, and integrin-RGD complex, respectively.
The association constant is related to the free energy of
association as follows:
ka ¼ e
DG
kBT ; (2)
where DG, kB, and T are the free energy of association per
mol, Boltzmann constant, and temperature, respectively.
Our simulations indicated that for the highly dynamic RGD
binding sites in the bTD-bA pocket, 10 ns is a reasonable
timescale for bonds to form and break down at least once
(see Fig. S1). As the free energy per mol of a significant elec-
trostatic bond in amino acids is typically taken as 5 kCal/mol
(55,56), substituting that value forDG in Eq. 2 and solving at
T ¼ 310 K yields ka~0.06 mol1. According to the ergodic
hypothesis in statistical thermodynamics, for a stochastic
system, any average of thermodynamic parameters over the
entire volume of the system at any instant in time equals
the average of the same parameter taken over a long time
span at a single point in the system (57). Hence, as a first
approximation, we can assume the free concentrations of
integrin and peptide (denoted as [I] and [P] in Eq. 1) are pro-
portional to the sumof time spans that the system experiences
the unbound state. On the other hand, the concentration
of the complex (denoted by [IP] in Eq. 1) is proportional to
the accumulative time period that the system spends in the
bound state. Therefore, the minimum association constant
for significant bond formations (ka ¼ 0.06 mol1) is corre-
sponding to a binding time of at least 3 ns within a simulation
scale of 10 ns. We defined bindings that remained associated
for> ~3 ns as permanent bonds and bindings with life spans
any shorter than 3 ns as temporary bonds.
Our simulations highlighted several binding sites for the
RGD peptide on integrin aIIbb3, most of which were eitherBiophysical Journal 105(6) 1304–1315inside or proximal to the bA-bTD pocket. Binding sites of
integrin aIIbb3 for RGD peptides in this region fell into
three distinct categories, wherein permanent interactions
always form at the Arg end of the RGD peptide. This could
be attributed to the highly basic side chain of the Arg that
facilitates formation of permanent salt bridges. The first
category featured bonds formed between the Arg of the
RGD peptide and integrin. Although this group included
permanent bindings, these bindings did not contribute to
detachment of the bA and bTD within our simulation time
because they were not able to disturb the key interaction
(i.e., K350 with S673 and S674). In the second type of inter-
actions, the Arg of the RGD peptide formed a permanent
bond with integrin aIIbb3, whereas the Asp of the RGD
peptide formed a temporary bond, which was highly fluctu-
ating and unstable. Finally, the third and most complex type
of RGD peptide-integrin interactions were composed of a
permanent interaction of the Arg of the RGD peptide with
integrin aIIbb3 at one end and a competitive, temporary
interaction of two other residues with the Asp of the RGD
peptide at the other end. Within the timescale of our simu-
lations (~13 ns), one out of two observed, type3 interactions
fully dethatched the bA domain from the bTD, which ac-
cording to both switchblade and dead- bolt models is equiv-
alent to integrin activation.
After ~7.5 ns of equilibration and free diffusion of the
RGD peptide in the vicinity of the bA-bTD pocket, as
depicted in Fig. 3, the key bA-bTD domain interactions
(i.e., K350 with S673 and S674) were disrupted as a result
of the Arg of the RGD side chain taking over the OH-group
on the side chain of S673. About 1 ns after the key interac-
tion was disrupted, the bTD swung open and the conforma-
tional change continued as the Asp of the RGD peptide was
engaged in two competing interactions with K600 on the
EGF3-EGF4 domain linker region and K611 on the EGF4
domain of the b3 subunit (see Fig. 3 e). These competing in-
teractions shifted the RGD peptide more toward the EGF3
and EGF4 domains, which furthered the distance between
the bA and bTD domains. It is worthwhile mentioning
that because Ser residues do not have significant avidity
for Lys, the two Ser residues together still do not maintain
K346 on the bA domain in a permanent salt bridge (i.e., a
bond distance of ~4 A˚). Hence, this rather weak interaction
combined with the strong basic identity of Arg side chains
may explain how integrin aIIbb3 is activated by a soluble,
RGD-containing ligand (e.g., fibrinogen).
It has been shown that fibrinogen binds an extensive inter-
face between the bA and b-propeller domains of the integrin
aIIbb3 head domain proximal to the metal ion-dependent
sites (i.e., MIDAS and ADMIDAS), which leads to integrin
activation (15,18,58). Aligned with previous studies, RGD1
and RGD2 interacted with the crevice region between the
bA and b-propeller on the head domain (20,21). However,
we did not observe any significant conformational changes
induced in integrin as a result of RGD binding to the head
On the Activation of Integrin aIIbb3 1313domain. This is aligned with a more recent study that
showed functional associations of fibrinogen with integrin
occur at the RGD-lacking gC peptide of fibrinogen (18).
Our study shed light on another important binding site for
the RGD motif inside the bA-bTD pocket that activates
integrin. Our simulations indicated that the pocket formed
by the bTD and bA domains of integrin is home to several
binding spots for the RGD peptide. Short-term interactions
between these binding spots and the RGD peptide increase
the residence time of the soluble RGD peptide near the
pocket, which escalates odds of an interaction occurring
between the RGD peptide and the key bonds between the
bTD and bA domains (i.e., K350 with S673 and S674),
which would lead to integrin activation via disrupting the
key interactions.
Two major mechanisms are reported to unlock the integ-
rin inhibitory interactions. Although the switchblade model
proposes a drastic change, from bent to fully stretched
conformation upon activation, the dead-bolt model suggests
more local conformational changes in the molecule due to
dissociation of the bTD and bA domains (13,23,34,42).
The switchblade model suggests that the interaction of the
integrin cytoplasmic domain with particular focal adhesion
proteins leads to a 135 rotation of the integrin head piece
relative to the tail piece. This rotation causes the bA-b-pro-
peller interface to face away from the plasma membrane,
thereby becoming available to interact with the ligand
(13,19). The switchblade model is corroborated for different
members of the integrin family by a number of previous
studies. First, when recombinant integrin a5b1 was artifi-
cially constrained with disulfide bonds in a bent conforma-
tion it did not associate with immobilized ligands (59). For
integrin avb3, a double mutation that held the head domain
against the leg domains via a Cys bridge hindered activation
(19). In addition, a significant increase in the protein Stokes
radius has been recorded for cases where integrins were
exposed to RGDFV peptides or Mn2þ (i.e., integrin activa-
tors) versus the case where they are in a Ca2þ buffer, which
is an activation inhibitor (19). However, integrin aIIbb3
activation paradigm appears to remain controversial, as
detailed monoclonal antibody epitope maps for inactive
and active integrin aIIbb3 in vivo demonstrated similar
compact forms consistent with the bent conformation
(23,60). Furthermore, binding of different ligand mimics
to integrin aIIbb3 in intact platelets has shown distinct
conformational changes in the receptor (61).
Another mechanistic explanation for integrin activation
was given by the dead-bolt model. The dead-bolt model
assumes that the elongated CD loop of the bTD locks the
bA domain via forming bonds with it in the inactive state
of the native structure, although the atomistic details of
these interactions are not currently clear (23). It is important
to note that the dead-bolt model does not necessarily ex-
clude a subsequent ligand-induced switchblade-like swing-
out. Interestingly enough, our simulations demonstratedthat the disruption in the interactions between the bTD
and bA domains could be a trigger for integrin activation,
recognizing electrostatic interactions of K350 on the bA
with S673 and S674 on the bTD as a potential regulatory
lock.
We observed that the dissociation of the bTD and bA do-
mains was succeeded by the bTD snap-back, which caused
the b-subunit transmembrane domain to slightly rotate (~3)
in a lever-like motion. This increase in the angle between
the a- and b-subunit transmembrane domains is also re-
ported by previous electron microscopy and biochemical
data as a potential activating mechanism for integrin aIIbb3
(21,52,54,62). However, another model is proposed for a
number of other integrin family members (e.g., a5b1) that
suggests the hinge region for the scissors-like motion of
integrin, upon activation, is located on the interface of the
a- and b-subunit head domains (59). We measured the elec-
trostatic energy between the a- and b-subunit transmem-
brane domains for the simulation with no RGD peptides
and compared it to the one in which the integrin activation
had been observed. Intriguingly, the electrostatic energy of
interaction appeared to decrease dramatically after the
bTD and bA domains separated. A slight rotation of the
long, transmembrane domain of the b-subunit could consid-
erably increase the distance between charged residues on the
a- and b-subunit transmembrane domains, which would
weaken the IMC. Therefore, we believe RGD interaction
with the bTD could be a potential trigger for the complete
separation of the transmembrane domains. Although this
set of data proposes a key interaction that might function
as a regulating dead-bolt, the loosening of the transmem-
brane domain clasps as a result of the bTD-bA domain sep-
aration suggests subsequent, more drastic conformational
changes, and explains how ligand-binding could lead to
the transmembrane domain separation as proposed by the
switchblade model. On the other hand, within the timescale
of our simulations, we did not observe any significant
conformational changes in the ectodomain nor did we see
any decreases in the bA-bTD interaction energy upon talin
binding with the b3 cytoplasmic tail. This suggests that
outside-in activation via RGD association with the key res-
idues embedded in the bA-bTD pocket occurs more rapidly
than inside-out activation followed by talin binding. It is
also noteworthy that distinct activation mechanisms and
conformational changes might be at work for different
combinations of integrin-ligand interactions.CONCLUSION
The activated state of integrin is commonly characterized
by three major dissociations: breaking of the IMC and
OMC, and unbinding of the bA and bTD (1,4,23,63).
This study attempted to explain the integrin aIIbb3 func-
tion, via exploring how these key interaction groups are
disrupted in specific pathways. Our observations of theBiophysical Journal 105(6) 1304–1315
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showed that the IMC is loosened with the presence of talin,
most likely through MP interactions that result from the
energetic compensation of the weakened IMC by K320 on
the S1-S2 loop of talin. We also found, using the full-length
crystal structure we built, that talin has a larger role in inte-
grin activation by disrupting an additional stable clasp
(R734-E1006) through the initial membrane-distal inter-
actions that anchors talin to integrin (2). Furthermore, we
used the full-length crystal structure of integrin aIIbb3 to
explore binding sites of soluble RGD ligands and their
ability to activate integrin aIIbb3 or maintain it in the acti-
vated state. We found three major groups of bindings with
two specific binding sites corresponding to each group.
According to our simulations, the major group of inter-
actions that maintains integrin aIIbb3 in the inactive, bent
state occurs between K350 on the bA domain, and S673
and S674 on the bTD. Interestingly, we observed the full
dissociation of the bTD and bA domains when this inter-
action group was disrupted and eventually removed as a
result of a competition between the Arg of the RGD peptide
with S674. Therefore, we proposed this molecular scenario
as a potential trigger mechanism for outside-in activation of
integrin aIIbb3 by soluble RGD ligand.SUPPORTING MATERIAL
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